These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7928218)

  • 1. Interaction of gadolinium complexes with metal-dependent biological systems.
    Corot C; Hentsch AM; Curtelin L
    Invest Radiol; 1994 Jun; 29 Suppl 2():S164-7. PubMed ID: 7928218
    [No Abstract]   [Full Text] [Related]  

  • 2. Gd-DTPA and Gd-DOTA effects on metabolism of glucose and phosphatidylinositols.
    Morris TW; Ekholm SE; Marinetti GV; Prentice LI; Leakey P
    Invest Radiol; 1991 Nov; 26 Suppl 1():S209-11; discussion S232-5. PubMed ID: 1808132
    [No Abstract]   [Full Text] [Related]  

  • 3. Acute hemodynamic effects of nonionic and ionic magnetic resonance contrast media in intravenous bolus injection in rats.
    Masui T; Takehara Y; Aoshima R; Kaneko M
    Invest Radiol; 1994 Jun; 29 Suppl 2():S189-91. PubMed ID: 7928226
    [No Abstract]   [Full Text] [Related]  

  • 4. Action of gadolinium complexes on different enzyme systems.
    Allard M; Caillé JM; Bonnemain B; Meyer D; Simonnet G
    Acta Radiol Suppl; 1986; 369():572-4. PubMed ID: 2980561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro interactions of gadolinium DOTA meglumine and gadolinium DTPA meglumine on hemostasis.
    Corot C; Belleville J; Paul J; Baguet J; Amiel M; Eloy R
    Invest Radiol; 1988 Sep; 23 Suppl 1():S261-3. PubMed ID: 3198358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [In vitro study of the action of DOTA and DTPA-gadolinium complexes on platelet functions: aggregation and calcium excretion].
    Corot C; Paul J; Belleville J; Eloy R
    J Radiol; 1988 Jan; 69(1):37-8. PubMed ID: 3361466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in the microcirculation of the intact rat heart after iodinated and gadolinium-containing contrast media.
    Klopp R; Niemer W; Schippel W; Krause W
    Invest Radiol; 1995 Feb; 30(2):69-74. PubMed ID: 7782189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Free gadolinium and gadodiamide, a gadolinium chelate used in magnetic resonance imaging: evaluation of their in vitro effects on human neutrophil viability.
    Behra-Miellet J; Gressier B; Brunet C; Dine T; Luyckx M; Cazin M; Cazin JC
    Methods Find Exp Clin Pharmacol; 1996 Sep; 18(7):437-42. PubMed ID: 8900215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of intra-articular gadolinium-DTPA on synovial membrane and cartilage.
    Hajek PC; Sartoris DJ; Gylys-Morin V; Haghighi P; Engel A; Kramer F; Neumann CH; Resnick D
    Invest Radiol; 1990 Feb; 25(2):179-83. PubMed ID: 2312253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical use of contrast media in magnetic resonance imaging.
    Bydder GM
    Br J Hosp Med; 1990 Feb; 43(2):149-52. PubMed ID: 2178714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of gadolinium-DTPA and -DOTA on neural tissue metabolism.
    Morris TW; Ekholm SE; Prentice LI
    Invest Radiol; 1991 Dec; 26(12):1087-90. PubMed ID: 1765443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The question of dose for gadolinium chelates in magnetic resonance imaging.
    Runge VM; Kirsch JE; Wells JW; Dunworth JN; Woolfolk CE
    Invest Radiol; 1994 Jun; 29 Suppl 2():S154-6. PubMed ID: 7928215
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of different classes of gadolinium-based contrast agents on control and nephrogenic systemic fibrosis-derived fibroblast proliferation.
    Edward M; Quinn JA; Burden AD; Newton BB; Jardine AG
    Radiology; 2010 Sep; 256(3):735-43. PubMed ID: 20663970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gadolinium phosphonates as MR imaging contrast agents: physiologic effects in rabbit hearts.
    Adzamli IK; Weinstein H; Leppo JA
    J Magn Reson Imaging; 1993; 3(6):821-8. PubMed ID: 8280969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amelioration of cardiodepressive effects of gadopentetate dimeglumine with addition of ionic calcium.
    Mühler A; Saeed M; Brasch RC; Higgins CB
    Radiology; 1992 Jul; 184(1):159-64. PubMed ID: 1609076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal handling and physiologic effects of the paramagnetic contrast medium, gadolinium-DOTA.
    Katzberg RW; Sahler LG; Duda SW; Morris TW; McKenna BA; Pabico RC; Niedrach WL; Tonetti FW
    Invest Radiol; 1991 Nov; 26 Suppl 1():S129-30; discussion S137-8. PubMed ID: 1808108
    [No Abstract]   [Full Text] [Related]  

  • 17. The need for electron paramagnetic resonance and water exchange-rate data for understanding small magnetic resonance imaging contrast agents and their macromolecular complexes.
    Koenig SH
    Invest Radiol; 1994 Jun; 29 Suppl 2():S127-30. PubMed ID: 7928207
    [No Abstract]   [Full Text] [Related]  

  • 18. Suppression of rabbit VX-2 subcutaneous tumor growth by gadolinium neutron capture therapy.
    Akine Y; Tokita N; Tokuuye K; Satoh M; Churei H; Le Pechoux C; Kobayashi T; Kanda K
    Jpn J Cancer Res; 1993 Aug; 84(8):841-3. PubMed ID: 8407547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of gadolinium DTPA on tissue water compartments in slow- and fast-twitch rabbit muscles.
    Adzamli IK; Jolesz FA; Bleier AR; Mulkern RV; Sandor T
    Magn Reson Med; 1989 Aug; 11(2):172-81. PubMed ID: 2779410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrocardiographic effects of diagnostic imaging agents.
    Wiggins J; Beckmann R; Weinmann HJ; Lehr R
    Acad Radiol; 2002 Aug; 9 Suppl 2():S444-6. PubMed ID: 12188303
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.